Clinical Trials Logo

Filter by:
NCT ID: NCT03125590 Completed - Osteopenia Clinical Trials

Validation, Reliability and Pilot Test of the Personalized Exercise Questionnaire (PEQ)

Start date: April 1, 2017
Phase: N/A
Study type: Observational

The PEQ is the first tool to measure facilitators, barriers, and preferences to exercise in people with osteoporosis.

NCT ID: NCT03125460 Completed - Bladder Cancer Clinical Trials

Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer

Start date: December 2016
Phase:
Study type: Observational

The objective of this study is to establish the performance characteristics of an assay that detects the recurrence of bladder cancer in patients previously diagnosed with bladder cancer. The study is conducted at locations within and outside of the United States. Testing is performed on urine specimens provided by eligible enrolled patients. Results from this study will not be used for patient management decisions.

NCT ID: NCT03125395 Completed - Cystic Fibrosis Clinical Trials

A Rollover Safety Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Years and Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation

Start date: May 12, 2017
Phase: Phase 3
Study type: Interventional

A Rollover Safety Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Years and Older With Cystic Fibrosis, Homozygous for F508del.

NCT ID: NCT03124589 Completed - Gambling Problem Clinical Trials

Comparing the Efficacy of an Online Gambling Intervention to a no Intervention Control Condition

Start date: April 21, 2017
Phase: N/A
Study type: Interventional

Online interventions for gambling problems hold a strong potential to help people with gambling concerns. However, there are no trials, to-date, that have been able to demonstrate the effectiveness of such an intervention. The current trial will compare participants provided access to an online gambling intervention to those assigned by chance to a no intervention condition in order to test the efficacy of one such Internet intervention for gambling. Participants will be recruited through Amazon's MTurk crowdsourcing platform. Potential participants identified as problem gamblers who are interested in quitting or reducing their gambling in the next 6 months, or often think about it, based on an initial survey will be invited to complete additional surveys at 6 weeks and 6 months. Those who then agree to be followed up will be randomized to access an online intervention for gambling or a no-intervention website. These participants will then be contacted again at 6 weeks and 6 months to ask about their gambling, and their impressions of the online intervention. The primary hypothesis to be tested is that participants receiving access to the online gambling intervention will report a greater reduction in number of days gambling and in NODS scores at 6-month follow-up than participants in the no intervention control condition.

NCT ID: NCT03124316 Completed - Clinical Trial Clinical Trials

Testing a Behavioural Approach to Improving Cancer Screening Rates

Start date: May 10, 2017
Phase: N/A
Study type: Interventional

Family doctors can play a critical role in successfully arranging cancer screening tests to occur, especially if they know which patients are due for these tests. However, they don't always interact with or take advantage of registry data to this end. For example, in Ontario, the Screening Activity Report provides exactly this information to family doctors, helping them identify their patients who are overdue for screening. Unfortunately, less than half of family doctors regularly use the Screening Activity Report even though they get monthly email reminders. One possible reason is that the reminders they receive are not designed to compel action. They are easy for family doctors to miss or dismiss. This study will compare multiple different ways of designing the reminders. The different versions of the email are tested in a 2^3 factorial trial testing three behaviour change techniques to see which ones will lead to more family physicians interacting with the Screening Activity Report and at increasing the number of patients that get all the appropriate screening tests for cervical, breast, and/or colon cancer.

NCT ID: NCT03124134 Completed - Obesity Clinical Trials

Gelesis Glycemic Index Study

GLIDE
Start date: April 18, 2017
Phase: N/A
Study type: Interventional

A study to determine glucose and insulin responses to 50g and 100 g of carbohydrate with and without Gelesis200.

NCT ID: NCT03123939 Completed - Clinical trials for Acute Lymphoblastic Leukemia

Phase III B in Acute Lymphoblastic Leukemia

Start date: April 24, 2017
Phase: Phase 3
Study type: Interventional

This is a single arm, open-label, multi-center, phase III B study to determine the safety and efficacy of CTL019 in pediatric/young adult patients with r/r B-cell Acute Lymphoblastic Leukemia (ALL).

NCT ID: NCT03123471 Completed - Psoriasis Clinical Trials

A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp

STYLE
Start date: May 16, 2017
Phase: Phase 3
Study type: Interventional

This is a Phase 3, multicenter, randomized, placebo-controlled, double-blind study of the efficacy and safety of apremilast (CC-10004) in subjects with moderate to severe plaque psoriasis of the scalp. Approximately 300 subjects with moderate to severe plaque psoriasis of the scalp will be randomized 2:1 to receive either apremilast 30 mg twice daily (BID) or placebo for the first 16 weeks.

NCT ID: NCT03123250 Completed - Clinical trials for Benign Prostatic Hyperplasia (BPH)

Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II

WATERII
Start date: August 14, 2017
Phase: N/A
Study type: Interventional

Single-arm, interventional pivotal clinical trial collecting patient data from use of the AQUABEAM System, a personalized image-guided waterjet resection system that utilizes a high-velocity saline stream to resect and remove prostate tissue in males suffering from Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Hyperplasia (BPH) with prostate volumes between 80 mL and 150 mL. The primary endpoints for safety and effectiveness will be measured at 3 months post-treatment. Treated subjects will be followed out to 60 months to collect long-term clinical data.

NCT ID: NCT03123146 Completed - Clinical trials for Autism Spectrum Disorder

Cognitive Behavioural Therapy for Children With Autism Spectrum Disorder and Obsessive Compulsive Behaviour

Start date: June 1, 2010
Phase: N/A
Study type: Interventional

Individuals with high functioning autism spectrum disorder (ASD) frequently experience obsessions and/or compulsions that are similar to those specified in Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5) criteria for obsessive compulsive disorder (OCD). However, little research exists on effective interventions for OCD symptoms (referred to as OCBs) in ASD. In a randomized controlled trial, a manualized functional behavior-based cognitive-behavior therapy (Fb-CBT) consisting of traditional CBT components (psychoeducation and mapping, cognitive-behavioral skills training, exposure, and response prevention) as well as function-based behavioral assessment will be evaluated. Participants will be assigned randomly to Fb-CBT or treatment as usual (TAU). Primary and secondary outcome measures will be used to evaluate the efficacy of the treatment, and will be administered at pre and post-intervention as well as six month follow-up.